Yildirim, S.; Odabas, H.; Ay Ersoy, S.; Orman, S.; Aydogan, M.; Turkoglu, E.; Akdag, G.; Bal, H.; Pekyurek Varan, M.; Isik, D.;
et al. Adjuvant Chemotherapy and Chemoradiotherapy in Gastric Cancer: Prognostic Determinants and Real-World Survival Outcomes. J. Clin. Med. 2026, 15, 553.
https://doi.org/10.3390/jcm15020553
AMA Style
Yildirim S, Odabas H, Ay Ersoy S, Orman S, Aydogan M, Turkoglu E, Akdag G, Bal H, Pekyurek Varan M, Isik D,
et al. Adjuvant Chemotherapy and Chemoradiotherapy in Gastric Cancer: Prognostic Determinants and Real-World Survival Outcomes. Journal of Clinical Medicine. 2026; 15(2):553.
https://doi.org/10.3390/jcm15020553
Chicago/Turabian Style
Yildirim, Sedat, Hatice Odabas, Seval Ay Ersoy, Seval Orman, Miray Aydogan, Ezgi Turkoglu, Goncagul Akdag, Hamit Bal, Melike Pekyurek Varan, Deniz Isik,
and et al. 2026. "Adjuvant Chemotherapy and Chemoradiotherapy in Gastric Cancer: Prognostic Determinants and Real-World Survival Outcomes" Journal of Clinical Medicine 15, no. 2: 553.
https://doi.org/10.3390/jcm15020553
APA Style
Yildirim, S., Odabas, H., Ay Ersoy, S., Orman, S., Aydogan, M., Turkoglu, E., Akdag, G., Bal, H., Pekyurek Varan, M., Isik, D., & Turan, N.
(2026). Adjuvant Chemotherapy and Chemoradiotherapy in Gastric Cancer: Prognostic Determinants and Real-World Survival Outcomes. Journal of Clinical Medicine, 15(2), 553.
https://doi.org/10.3390/jcm15020553
